Back to search
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Data up to Jan 2025
Published2013
Citations152
References0
Clinical Trials (1)
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...